Drug Design Studies of Carbonic Anhydrase Activators

Drug Design of Zinc-Enzyme Inhibitors: Functional, Structural, and Disease Applications

Volumn , Issue , 2009, Pages 473-486

  Temperini, Claudia ^a   Scozzafava, Andrea ^a   Supuran, Claudiu T ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Carbonic anhydrase II activation; Drug design studies of carbonic anhydrase activators; Human brain carbonic anhydrase isoform activation

Indexed keywords

EID: 84889439904     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470508169.ch22     Document Type: Chapter

References (38)

1. Mann, T.; Keilin, D. Sulphanilamide as a specific inhibitor of carbonic anhydrase. Nature 1940, 146, 164-165.
2. Supuran, C. T.; Scozzafava, A. Carbonic anhydrase inhibitors. Curr. Med. Chem. Imm. Endoc. Metab. Agents 2001, 1, 61-97.
3. Supuran, C. T.; Scozzafava, A. Carbonic anhydrase inhibitors and their therapeutic potential. Expert Opin. Ther. Pat. 2000, 10, 575-600.
4. Leiner, M. Das Ferment Kohlens€aureanhydrase im Tierk€orper. Naturwissenschaften 1940, 28, 316-317.
5. Leiner, M.; Leiner, G. Die Aktivatoren der Kohlens€aureanhydrase. Naturwissenschaften 1941, 29, 195-197.
6. Leiner, M.; Leiner, G. Die Messmethoden zur Untersuchung der katalytischen Wirksamkeit der Kohlens€aureanhydrase. Biochem. Z. 1941, 311, 119-145.
7. Kiese, M. Die Aktivierung der Kohlens€aureanhydrase. Naturwissenschaften 1941, 29, 116-117.
8. van Goor,H. Carbonic anhydrase: its properties, distribution and significance for carbon dioxide transport. Enzymologia 1948, 13, 73-164.
9. Supuran, C. T.; Scozzafava, A. Activation of carbonic anhydrase isozymes. In The Carbonic Anhydrases: New Horizons; Chegwidden, W. R.; Carter, N.; Edwards, Y., Eds.; Birkhauser Verlag: Basel, Switzerland, 2000; pp 197-219.
10. Clark, A. M.; Perrin, D. D. A reinvestigation of the question of activators of carbonic anhydrase. Biochem. J. 1951, 48, 495-503.
11. Roughton, F. J.W.; Booth, H. The effect of substrate concentration, pH and other factors upon the activity of carbonic anhydrase. Biochem. J. 1946, 40, 319-329.
12. Maren, T. H. Carbonic anhydrase: chemistry, physiology and inhibition. Physiol. Rev. 1967, 47, 595-781.
13. Lindskog, S. Structure and mechanism of carbonic anhydrase. Pharmacol. Ther. 1997, 74, 1-20.
14. Sly, W. S.; Hu, P. Y. Human carbonic anhydrases and carbonic anhydrase deficiencies. Annu. Rev. Biochem. 1995, 64, 375-401.
15. Stams, T.; Christianson, D. W. X-ray crystallographic studies of mammalian carbonic anhydrase isozymes. In The Carbonic Anhydrases: New Horizons; Chegwidden, W. R.; Edwards, Y.; Carter, N., Eds.; Birkh€auser Verlag: Basel, Switzerland, 2000; pp 159-174.
16. Meier-Ruge, W.; Iwangoff, P.; Reichlmeier, K. Neurochemical enzyme changes in Alzheimer's and Pick's disease. Arch. Gerontol. Geriatr. 1984, 3, 161-165.
17. Briganti, F.; Mangani, S.; Orioli, P.; Scozzafava, A.; Vernaglione, G.; Supuran, C. T. Carbonic anhydrase activators: X-ray crystallographic and spectroscopic investigations for the interaction of isozymes I and II with histamine. Biochemistry 1997, 36, 10384-10392.
18. Briganti, F.; Iaconi, V.; Mangani, S.; Orioli, P.; Scozzafava, A.; Vernaglione, G.; Supuran, C. T. A ternary complex of carbonic anhydrase: X-ray crystallographic structure of the adduct of human carbonic anhydrase II with the activator phenylalanine and the inhibitor azide. Inorg. Chim. Acta 1998, 275-276, 295-300.
19. Temperini, C.; Scozzafava, A.; Puccetti, L.; Supuran, C. T. Carbonic anhydrase activators:X-ray crystal structure of the adduct of human isozyme II with L-histidine as a platform for the design of stronger activators. Bioorg. Med. Chem. Lett. 2005, 15, 5136-5141.
20. Temperini, C.; Scozzafava, A.; Vullo, D.; Supuran, C. T. Carbonic anhydrase activators. Activation of isoforms I, II, IV, VA, VII, and XIV with L- and D-phenylalanine and crystallographic analysis of their adducts with isozyme II: stereospecific recognition within the active site of an enzyme and its consequences for the drug design. J. Med. Chem. 2006, 49, 3019-3027.
21. Temperini, C.; Scozzafava, A.; Vullo, D.; Supuran, C. T. Carbonic anhydrase activators. Activation of isozymes I, II, IV, VA, VII, and XIV with L- and D-histidine and crystallographic analysis of their adducts with isoform II: engineering proton-transfer processes within the active site of an enzyme. Chemistry 2006, 12, 7057-7066.
22. Temperini, C.; Innocenti, A.; Scozzafava, A.; Mastrolorenzo, A.; Supuran, C. T. Carbonic anhydrase activators: L-adrenaline plugs the active site entrance of isozyme II, activating better isoforms I, IV, VA, VII, and XIV. Bioorg. Med. Chem. Lett. 2007, 17, 628-635.
23. Clare, B. W.; Supuran, C. T. Carbonic anhydrase activators. Part 3. Structure-activity correlations for a series of isozyme II activators. J. Pharm. Sci. 1994, 83, 768-779.
24. Sun, M. K.; Alkon, D. L. Pharmacological enhancement of synaptic efficacy, spatial learning and memory through carbonic anhydrase activation in rats. J. Pharmacol. Exp. Ther. 2001, 29, 961-967.
25. Sun, M. K.; Alkon, D. L. Carbonic anhydrase gating of attention: memory therapy and enhancement. Trends Pharmacol. Sci. 2002, 23, 83-89.
26. Korolainen, M. A.; Goldsteins, G.; Nyman, T. A.; Alafuzoff, I.; Koistinaho, J.; Pirttila, T. Oxidative modification of proteins in the frontal cortex of Alzheimer's disease brain. Neurobiol. Aging 2006, 27, 42-53.
27. Sultana, R.; Poon, H. F.; Cai, J.; Pierce,W. M.; Merchant, M.; Klein, J. B.; Markesbery,W. R.; Butterfield, D. A. Identification of nitrated proteins in Alzheimer's disease brain using a redox proteomics approach. Neurobiol. Dis. 2006, 22, 76-87.
28. Poon, H. F.; Frasier, M.; Shreve, N.; Calabrese, V.; Wolozin, B.; Butterfield, D. A. Mitochondrial associated metabolic proteins are selectively oxidized in A30P a-synuclein transgenic mice: a model of familial Parkinson's disease. Neurobiol. Dis. 2005, 18, 492-498.
29. Izumi, M.;Yamazaki, H.; Nakabayashi, H.;Owada, M. Magnetic resonance imaging of the brain in phenylketonuria. No To Hattatsu 2006, 38, 27-31.
30. Parkkila, S.; Parkkila, A. K.; Kivela, J. Role of carbonic anhydrase and its inhibitors in biological science related to gastroenterology, neurology and nephrology. In Carbonic Anhydrase: Its Inhibitors and Activators; Supuran, C. T.; Scozzafava, A.; Conway, J., Eds.; CRC Press: Boca Raton, FL, 2004; pp 283-302.
31. Khalifah, R. G. The carbon dioxide hydration activity of carbonic anhydrase. I. Stop-flow kinetic studies on the native human isoenzymes B and C. J. Biol. Chem. 1971, 246, 2561-2573.
32. Hoffman, B. B.; Lefkowitz, R. J. Catecholamines, sympathomimetic drugs, and adrenergic receptor antagonists. In Goodman & Gilman's The Pharmacological Basis of Therapeutics, Hardman, J. G.; Limbird, L. E.; Molinoff, P. B.; Ruddon, R.W.; Goodman Gilman, A., 9th ed.; McGraw-Hill: New York, 1996; p 199.
33. Scozzafava, A.; Mastrolorenzo, A.; Supuran, C. T. Modulation of carbonic anhydrase activity and its applications in therapy. Expert Opin. Ther. Pat. 2004, 14, 667-702.
34. Supuran, C.T.; Scozzafava,A. Carbonic anhydrase activators as potential anti-Alzheimer's disease agents. In Protein Misfolding in Neurodegenerative Diseases: Mechanisms and Therapeutic Strategies; Smith, H. J; Simons, C.; Sewell, R. D. E., Eds.; CRC Press: Boca Raton, FL, 2008; pp 265-288.
35. Innocenti, A.; Firnges, M. A.; Antel, J.;Wurl, M.; Scozzafava, A.; Supuran, C. T. Carbonic anhydrase inhibitors. Inhibition of the membrane-bound human and bovine isozymes IV with sulfonamides. Bioorg. Med. Chem. Lett. 2005, 15, 1149-1154.
36. Nair, S. K.; Christianson, D. W. Unexpected pH-dependent conformation of His-64, the proton shuttle of carbonic anhydrase II. J. Am. Chem. Soc. 1991, 113, 9455-9458.
37. Christianson, D.W.; Fierke, C. A. Carbonic anhydrase: evolution of the zinc binding site by nature and by design. Acc. Chem. Res. 1996, 29, 331-339.
38. Igbo, I. N.; Reigel, C. E., Jr.; Greene, I. M.;Kenny,A.D. Effect of reserpine pretreatment on avian erythrocyte carbonic anhydrase activation by isoproterenol. Pharmacology 1994, 49, 112-120.